These findings provide new concepts that hispidulin sensitizes cancer cells to TRAIL-induced apoptosis via CaMKKβ/AMPK/USP51-mediated Bim stabilization as a therapeutic strategy for cancer treatment. This evidence concerns the gene CAMKK2 and cancer.